BrightSpring Health Services (BTSG) EBIT (2023 - 2026)

BrightSpring Health Services has reported EBIT for 4 years, with the latest figure at $121.4 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 139.36% year-over-year to $121.4 million; the trailing twelve-month figure through Mar 2026 stood at $99.7 million (down 42.72% YoY), and the FY2025 full-year result was $29.0 million, down 73.17% from the prior year.
• EBIT for Q1 2026 stood at $121.4 million, up from -$158.2 million in the prior quarter.
• The five-year high for EBIT was $121.4 million in Q1 2026, with the low at -$158.2 million in Q4 2025.
• Historically, EBIT has averaged $16.4 million across 4 years, with a median of $48.6 million in 2025.
• The largest YoY upside for EBIT was 430.87% in 2025 against a maximum downside of 384.79% in 2025.
• BrightSpring Health Services' EBIT stood at -$123.8 million in 2023, then jumped by 144.86% to $55.5 million in 2024, then tumbled by 384.79% to -$158.2 million in 2025, then jumped by 176.78% to $121.4 million in 2026.
• The last three EBIT figures came in at $121.4 million (Q1 2026), -$158.2 million (Q4 2025), and $87.8 million (Q3 2025), per Business Quant data.